Ticker
ARVNCompany Name
ARVINAS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity | Net Income Common Stock | Return on Equity |
---|---|---|---|
6/30/2025 | $ 609.3M | $ -72.6M | -11.92% |
3/31/2025 | $ 660.1M | $ -46.6M | -7.06% |
12/31/2024 | $ 561.7M | $ -198.9M | -35.41% |
9/30/2024 | $ 586M | $ -308.6M | -52.66% |
6/30/2024 | $ 600.2M | $ -323.4M | -53.88% |
3/31/2024 | $ 609.7M | $ -354.8M | -58.19% |
12/31/2023 | $ 660M | $ -367.3M | -55.65% |
9/30/2023 | $ 457.2M | $ -295.4M | -64.61% |
6/30/2023 | $ 463.6M | $ -297.6M | -64.19% |
3/31/2023 | $ 511M | $ -301M | -58.9% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Equity
(=) ROE
ROE for ARVINAS INC is calculated as follows: Net Inc. Cmn. [ $ -98.83M ] / Equity [ $ 205.12M ]
(=) ROE [ -48.18% ]
Minimum
Sep 30, 2023
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.14K |
---|---|
min | -66.79% |
max | 73.25% |
average | 1.51% |
median | 6.45% |
std | 22.67% |